Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiomyopathy, Hypertrophic | 10 | 2024 | 1300 | 2.150 |
Why?
|
Benzylamines | 8 | 2024 | 248 | 1.810 |
Why?
|
Uracil | 7 | 2024 | 207 | 1.710 |
Why?
|
Heart Failure | 24 | 2024 | 11835 | 1.070 |
Why?
|
Influenza Vaccines | 5 | 2024 | 770 | 0.980 |
Why?
|
Influenza, Human | 7 | 2024 | 1532 | 0.900 |
Why?
|
Ventricular Function, Left | 10 | 2024 | 3870 | 0.890 |
Why?
|
Stroke Volume | 15 | 2024 | 5513 | 0.890 |
Why?
|
Echocardiography | 7 | 2024 | 4980 | 0.610 |
Why?
|
Cardiac Myosins | 3 | 2023 | 124 | 0.570 |
Why?
|
Virus Diseases | 1 | 2023 | 721 | 0.570 |
Why?
|
Progeria | 2 | 2024 | 188 | 0.380 |
Why?
|
Heart | 2 | 2023 | 4392 | 0.330 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15273 | 0.310 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2024 | 1025 | 0.300 |
Why?
|
Exercise | 4 | 2023 | 5783 | 0.290 |
Why?
|
Atherosclerosis | 3 | 2019 | 3524 | 0.280 |
Why?
|
Cardiovascular Diseases | 6 | 2024 | 15740 | 0.270 |
Why?
|
Double-Blind Method | 7 | 2024 | 12412 | 0.250 |
Why?
|
Motor Activity | 1 | 2015 | 2687 | 0.250 |
Why?
|
Heparin | 2 | 2021 | 1655 | 0.230 |
Why?
|
Atrial Function, Left | 1 | 2023 | 186 | 0.190 |
Why?
|
Psychomotor Agitation | 1 | 2023 | 306 | 0.190 |
Why?
|
Aged | 22 | 2024 | 168995 | 0.180 |
Why?
|
Exercise Tolerance | 2 | 2021 | 826 | 0.170 |
Why?
|
Mortality | 3 | 2021 | 2916 | 0.170 |
Why?
|
Biphenyl Compounds | 1 | 2024 | 988 | 0.170 |
Why?
|
Glomerular Filtration Rate | 2 | 2024 | 2178 | 0.160 |
Why?
|
Polypharmacy | 1 | 2021 | 307 | 0.160 |
Why?
|
Drug Combinations | 1 | 2024 | 2024 | 0.150 |
Why?
|
Spironolactone | 1 | 2021 | 411 | 0.150 |
Why?
|
Immunization Schedule | 1 | 2019 | 225 | 0.150 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2024 | 1038 | 0.140 |
Why?
|
Thrombosis | 2 | 2021 | 3052 | 0.140 |
Why?
|
Humans | 40 | 2024 | 760261 | 0.140 |
Why?
|
Argentina | 1 | 2017 | 245 | 0.140 |
Why?
|
Hypertension | 2 | 2016 | 8595 | 0.130 |
Why?
|
Male | 27 | 2024 | 359413 | 0.130 |
Why?
|
Death, Sudden | 1 | 2018 | 302 | 0.130 |
Why?
|
Middle Aged | 21 | 2024 | 220175 | 0.130 |
Why?
|
Anticoagulants | 2 | 2021 | 4896 | 0.130 |
Why?
|
Hospitalization | 5 | 2024 | 10761 | 0.120 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5201 | 0.120 |
Why?
|
Leisure Activities | 1 | 2016 | 306 | 0.120 |
Why?
|
Ventricular Remodeling | 2 | 2024 | 1259 | 0.120 |
Why?
|
Female | 27 | 2024 | 391011 | 0.110 |
Why?
|
Risk Factors | 11 | 2024 | 74269 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 2 | 2019 | 1572 | 0.110 |
Why?
|
Diastole | 1 | 2016 | 788 | 0.110 |
Why?
|
Brazil | 1 | 2017 | 1214 | 0.110 |
Why?
|
Prognosis | 4 | 2024 | 29636 | 0.110 |
Why?
|
Malnutrition | 1 | 2019 | 638 | 0.100 |
Why?
|
Medical Oncology | 1 | 2024 | 2321 | 0.100 |
Why?
|
Canada | 1 | 2017 | 2128 | 0.100 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2014 | 491 | 0.100 |
Why?
|
Treatment Outcome | 6 | 2024 | 64947 | 0.090 |
Why?
|
Athletes | 1 | 2018 | 1125 | 0.090 |
Why?
|
Cardiomyopathies | 1 | 2022 | 1945 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2021 | 1809 | 0.090 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2015 | 853 | 0.090 |
Why?
|
Kidney | 1 | 2024 | 7072 | 0.080 |
Why?
|
Students | 1 | 2018 | 1722 | 0.080 |
Why?
|
Fibrosis | 1 | 2015 | 2042 | 0.080 |
Why?
|
United States | 6 | 2023 | 72363 | 0.070 |
Why?
|
Heart Arrest | 1 | 2018 | 1506 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3310 | 0.070 |
Why?
|
Risk Assessment | 3 | 2024 | 24086 | 0.070 |
Why?
|
Heart Defects, Congenital | 1 | 2023 | 4668 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2023 | 1256 | 0.060 |
Why?
|
Heart Ventricles | 1 | 2017 | 3811 | 0.060 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 2024 | 87 | 0.060 |
Why?
|
Aortic Valve | 1 | 2014 | 1996 | 0.060 |
Why?
|
Mass Screening | 1 | 2018 | 5422 | 0.050 |
Why?
|
Diabetes Mellitus | 2 | 2018 | 5884 | 0.050 |
Why?
|
Aged, 80 and over | 7 | 2024 | 58947 | 0.050 |
Why?
|
Neprilysin | 1 | 2024 | 472 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39254 | 0.050 |
Why?
|
Vaccines, Inactivated | 1 | 2021 | 180 | 0.040 |
Why?
|
Incidence | 4 | 2019 | 21378 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12532 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2021 | 346 | 0.040 |
Why?
|
Hemorrhage | 2 | 2021 | 3604 | 0.040 |
Why?
|
Wisconsin | 1 | 2018 | 122 | 0.040 |
Why?
|
Tetrazoles | 1 | 2024 | 901 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12281 | 0.040 |
Why?
|
Survival Analysis | 2 | 2021 | 10185 | 0.040 |
Why?
|
Glucosides | 1 | 2022 | 536 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1723 | 0.040 |
Why?
|
Hospital Mortality | 2 | 2021 | 5420 | 0.040 |
Why?
|
Sodium | 1 | 2022 | 1601 | 0.040 |
Why?
|
Sex Factors | 2 | 2023 | 10530 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2020 | 694 | 0.040 |
Why?
|
Adult | 8 | 2024 | 219847 | 0.040 |
Why?
|
Denmark | 1 | 2019 | 759 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2019 | 725 | 0.030 |
Why?
|
Myocardial Infarction | 3 | 2024 | 11891 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 942 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22066 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2646 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 25928 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2020 | 1840 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 864 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3433 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54263 | 0.030 |
Why?
|
Universities | 1 | 2018 | 983 | 0.030 |
Why?
|
Troponin T | 1 | 2018 | 774 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2024 | 3145 | 0.030 |
Why?
|
Independent Living | 1 | 2016 | 568 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2022 | 2627 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2063 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8621 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8553 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4361 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3360 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2623 | 0.020 |
Why?
|
Hemodynamics | 1 | 2020 | 4169 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2024 | 2296 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2018 | 1004 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2018 | 1705 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2058 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9712 | 0.020 |
Why?
|
Cause of Death | 1 | 2019 | 3723 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2709 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6361 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6545 | 0.020 |
Why?
|
Time Factors | 2 | 2019 | 40133 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14482 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10340 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13311 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8058 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4081 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2018 | 5120 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4763 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 3149 | 0.020 |
Why?
|
Animals | 1 | 2015 | 167940 | 0.010 |
Why?
|
Insulin | 1 | 2018 | 6592 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10552 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12806 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22041 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15827 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8449 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 5960 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15687 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12968 | 0.010 |
Why?
|
Obesity | 1 | 2016 | 12915 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 87747 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 80301 | 0.010 |
Why?
|
Concepts
(147)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_